Paradoxical Effects of Glucocorticoids on Regulation of Plasminogen Activator Activity of Rat Hepatoma Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1982 Apr 1

PMID 6179095

Citations 5

Authors

T D Gelehrter

Affiliations

Soon will be listed here.

Abstract

Incubation of rat hepatoma cells with cAMP derivatives stimulates cell-associated plasminogen activator activity 8- to 22-fold and extracellular plasminogen activator activity 30- to 1300-fold. This time- and concentration-dependent increase is enhanced by phosphodiesterase inhibitors. Dexamethasone, a synthetic glucocorticoid, decreases the plasminogen activator activity of these cells, probably through induction of an inhibitor. Paradoxically, dexamethasone, added simultaneously with cAMP derivatives causes a further 4-fold enhancement of the cAMP-mediated stimulation of plasminogen activator activity. Dexamethasone also alters the time course of cAMP-mediated enhancement of plasminogen activator activity: increased protease activity is detected at 4 hr in cells incubated with 8-bromoadenosine-3':5'-cyclic monophosphoric acid and 1-methyl-3-isobutylxanthine but not until 12 hr in cells incubated with dexamethasone as well. Glucocorticoids thus exert two separate and opposite effects on plasminogen activator activity: induction of an inhibitor and amplification of cyclic nucleotide action. Although permissive and synergistic effects of dexamethasone on cyclic nucleotide action have been reported previously, glucocorticoid regulation of plasminogen activator activity is unique in that the amplification of cyclic nucleotide effects by dexamethasone opposes its regulatory action toward a specific enzyme.

Citing Articles

Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Peppa M, Krania M, Raptis S Integr Blood Press Control. 2011; 4:7-16.

PMID: 21949634 PMC: 3172078. DOI: 10.2147/IBPC.S9486.

Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.

Kastelan D, Dusek T, Kraljevic I, Polasek O, Giljevic Z, Solak M Endocrine. 2009; 36(1):70-4.

PMID: 19381886 DOI: 10.1007/s12020-009-9186-y.

Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome.

Fatti L, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci P J Endocrinol Invest. 2000; 23(3):145-50.

PMID: 10803470 DOI: 10.1007/BF03343697.

Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

Loskutoff D, van Mourik J, Erickson L, Lawrence D Proc Natl Acad Sci U S A. 1983; 80(10):2956-60.

PMID: 6574465 PMC: 393952. DOI: 10.1073/pnas.80.10.2956.

Hormonal regulation of plasminogen activator in rat hepatoma cells.

Gelehrter T, Coleman P, Cwikel B Mol Cell Biochem. 1983; 53-54(1-2):11-21.

PMID: 6312282 DOI: 10.1007/BF00225243.

References

Strickland S, Beers W . Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins. J Biol Chem. 1976; 251(18):5694-702. View

Laishes B, Roberts E, Burrowes C . Fibrinolytic activity of adult rat liver cells in primary culture and inhibition by glucocorticoids. Biochem Biophys Res Commun. 1976; 72(2):462-71. DOI: 10.1016/s0006-291x(76)80065-4. View

Linney E, Levinson B . Teratocarcinoma differentiation: plasminogen activator activity associated with embryoid body formation. Cell. 1977; 10(2):297-304. DOI: 10.1016/0092-8674(77)90223-9. View

Werb Z, Mainardi C, Vater C, Harris Jr E . Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med. 1977; 296(18):1017-23. DOI: 10.1056/NEJM197705052961801. View

Rousseau G . Activity of protein kinase dependent on adenosine 3':5'-monophosphate and of its thermostable protein inhibitor in rat hepatoma (HTC) cells. Unlikely role in the permissive action of glucocorticoids. Eur J Biochem. 1977; 76(1):309-16. DOI: 10.1111/j.1432-1033.1977.tb11597.x. View

Granelli-Piperno A, Vassalli J, Reich E . Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med. 1977; 146(6):1693-706. PMC: 2181898. DOI: 10.1084/jem.146.6.1693. View

Lacroix M, Smith F, Fritz I . Secretion of plasminogen activator by Sertoli cell enriched cultures. Mol Cell Endocrinol. 1977; 9(2):227-36. DOI: 10.1016/0303-7207(77)90124-1. View

Granelli-Piperno A, Reich E . A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med. 1978; 148(1):223-34. PMC: 2184915. DOI: 10.1084/jem.148.1.223. View

Werb Z . Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions. J Exp Med. 1978; 147(6):1695-1712. PMC: 2184323. DOI: 10.1084/jem.147.6.1695. View

10.

Beers W, Strickland S, Reich E . Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell. 1975; 6(3):387-94. DOI: 10.1016/0092-8674(75)90188-9. View

11.

Rosen N, Schneck J, Bloom B, Rosen O . Inhibition of plasminogen activator secretion by cyclic AMP in a macrophage-like cell line. J Cyclic Nucleotide Res. 1978; 4(5):345-58. View

12.

Miskin R, Easton T, Reich E . Plasminogen activator in chick embryo muscle cells: induction of enzyme by RSV, PMA and retinoic acid. Cell. 1978; 15(4):1301-12. DOI: 10.1016/0092-8674(78)90055-7. View

13.

Kucherlapati R, Tepper R, Granelli-Piperno A, Reich E . Modulation and mapping of a human plasminogen activator by cell fusion. Cell. 1978; 15(4):1331-40. DOI: 10.1016/0092-8674(78)90058-2. View

14.

Seifert S, Gelehrter T . Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells. Proc Natl Acad Sci U S A. 1978; 75(12):6130-3. PMC: 393132. DOI: 10.1073/pnas.75.12.6130. View

15.

Wilson E, Reich E . Modulation of plasminogen activator synthesis in chick embryo fibroblasts by cyclic nucleotides and phorobol myristate acetate. Cancer Res. 1979; 39(5):1579-86. View

16.

Seifert S, Gelehrter T . Isolation of rat hepatoma cell variants selectively resistant to dexamethasone inhibition of plasminogen activator. J Cell Physiol. 1979; 99(3):333-41. DOI: 10.1002/jcp.1040990308. View

17.

Thompson E, GRANNER D, Gelehrter T, Erickson J, Hager G . Unlinked control of multiple glucocorticoid-induced processes in HTC cells. Mol Cell Endocrinol. 1979; 15(3):135-50. DOI: 10.1016/0303-7207(79)90034-0. View

18.

Gelehrter T . Glucocorticoids and the plasma membrane. Monogr Endocrinol. 1979; 12:561-74. DOI: 10.1007/978-3-642-81265-1_30. View

19.

GRANNER D . The role of glucocorticoid hormones as biological amplifiers. Monogr Endocrinol. 1979; 12:593-611. DOI: 10.1007/978-3-642-81265-1_33. View

20.

Shepro D, Schleef R, Hechtman H . Plasminogen activator activity by cultured bovine aortic endothelial cells. Life Sci. 1980; 26(6):415-22. DOI: 10.1016/0024-3205(80)90159-9. View